相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Metabolic syndrome and clinical outcomes in patients infected with COVID-19: Does age, sex, and race of the patient with metabolic syndrome matter?
Prateek Lohia et al.
JOURNAL OF DIABETES (2021)
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China
Dawei Wang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
Nanshan Chen et al.
LANCET (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
Clinical Characteristics of Coronavirus Disease 2019 in China
W. Guan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China
Ruchong Chen et al.
CHEST (2020)
Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction
Thomas Menter et al.
HISTOPATHOLOGY (2020)
Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis
Jing Yang et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State
Matt Arentz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis
Zhaohai Zheng et al.
JOURNAL OF INFECTION (2020)
Hiding in Plain Sight: an Approach to Treating Patients with Severe COVID-19 Infection
David S. Fedson et al.
mBio (2020)
Acute kidney injury in patients hospitalized with COVID-19
Jamie S. Hirsch et al.
KIDNEY INTERNATIONAL (2020)
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
Maximilian Ackermann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Statin therapy in COVID-19 infection
Vincenzo Castiglione et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2020)
Considerations for Statin Therapy in Patients with COVID-19
Simin Dashti-Khavidaki et al.
PHARMACOTHERAPY (2020)
Meta-analysis of Effect of Statins in Patients with COVID-19
Chia Siang Kow et al.
AMERICAN JOURNAL OF CARDIOLOGY (2020)
Statins: Could an old friend help in the fight against COVID-19?
Raul R. Rodrigues-Diez et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science
Paul C. Evans et al.
CARDIOVASCULAR RESEARCH (2020)
In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19
Xiao-Jin Zhang et al.
CELL METABOLISM (2020)
Impact of cerebrovascular and cardiovascular diseases on mortality and severity of COVID-19-systematic review, meta-analysis, and meta-regression
Raymond Pranata et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2020)
Factors associated with COVID-19-related death using OpenSAFELY
Elizabeth J. Williamson et al.
NATURE (2020)
Incidence of thrombotic complications in critically ill ICU patients with COVID-19
F. A. Klok et al.
THROMBOSIS RESEARCH (2020)
Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study
Giacomo Grasselli et al.
LANCET RESPIRATORY MEDICINE (2020)
Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States
Bruce Bode et al.
JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY (2020)
Atorvastatin associated with decreased hazard for death in COVID-19 patients admitted to an ICU: a retrospective cohort study
Guillermo Rodriguez-Nava et al.
CRITICAL CARE (2020)
Statins and the COVID-19 main protease: in silico evidence on direct interaction
Zeljko Reiner et al.
ARCHIVES OF MEDICAL SCIENCE (2020)
Atorvastatin restricts the ability of influenza virus to generate lipid droplets and severely suppresses the replication of the virus
Donna Episcopio et al.
FASEB JOURNAL (2019)
Association of Elevated Plasma Interleukin-18 Level With Increased Mortality in a Clinical Trial of Statin Treatment for Acute Respiratory Distress Syndrome*
Angela J. Rogers et al.
CRITICAL CARE MEDICINE (2019)
Statins Suppress Ebola Virus Infectivity by Interfering with Glycoprotein Processing
Punya Shrivastava-Ranjan et al.
MBIO (2018)
Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial
Carolyn S. Calfee et al.
LANCET RESPIRATORY MEDICINE (2018)
Statin therapy in patients with community-acquired pneumonia
Frances S. Grudzinska et al.
CLINICAL MEDICINE (2017)
Treating Ebola patients: a 'bottom up' approach using generic statins and angiotensin receptor blockers
David S. Fedson et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2015)
Statins May Decrease the Fatality Rate of Middle East Respiratory Syndrome Infection
Shu Yuan
MBIO (2015)
Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection
Allison L. Totura et al.
MBIO (2015)
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Neil J. Stone et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Inhibition of NF-κB-Mediated Inflammation in Severe Acute Respiratory Syndrome Coronavirus-Infected Mice Increases Survival
Marta L. DeDiego et al.
JOURNAL OF VIROLOGY (2014)
Simvastatin in the Acute Respiratory Distress Syndrome
Daniel F. McAuley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Rosuvastatin for Sepsis-Associated Acute Respiratory Distress Syndrome
Jonathon D. Truwit et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Treating influenza with statins and other immunomodulatory agents
David S. Fedson
ANTIVIRAL RESEARCH (2013)
Inhibition of protein geranylgeranylation and farnesylation protects against graft-versus-host disease via effects on CD4 effector T cells
Anne-Kathrin Hechinger et al.
HAEMATOLOGICA (2013)
Influenza and COPD mortality protection as pleiotropic, dose-dependent effects of statins
Floyd J. Frost et al.
CHEST (2007)
Statins and the vascular endothelial inflammatory response
John Greenwood et al.
TRENDS IN IMMUNOLOGY (2007)
Intensive lipid lowering with atorvastatin in patients with stable coronary disease
JC LaRosa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Intensive versus moderate lipid lowering with statins after acute coronary syndromes
CP Cannon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Effect of pravastatin on plasma markers of inflammation and peripheral endothelial function in male heart transplant recipients
T Holm et al.
AMERICAN JOURNAL OF CARDIOLOGY (2001)
分享论文
